Katie Thurston reveals her HER2-negative breast cancer is treated with hormone therapy instead of chemo, detailing her custom treatment plan.

Researchers evaluated current treatment patterns and clinical outcomes for patients with HER2-positive metastatic breast cancer.

Researchers have found new compounds that could be used to treat a common breast cancer that can be resistant to hormone ...

Fengting Yan, MD, PhD, discusses how her clinical practice is informed by data and guidelines available on testing in breast cancer.

“This new combination treatment offers an additional option for some people whose breast cancer has progressed despite previous hormone therapy, and who may benefit from a targeted approac ...

To say the last few years of Olivia Munn’s life have been a rollercoaster doesn’t fully capture what she’s been through.

She also had a lymph node transplant, but her arm needed more treatment. Weight gain worsens lymphedema, but many breast cancer survivors must take hormone blockers, which can lead them to put on ...

The tablet capivasertib, used alongside fulvestrant, has been approved for patients with hormone receptor-positive, HER2-negative breast cancer that has progressed after earlier endocrine treatment.

Triple-negative breast cancer ... The hormone insulin plays a key role in the development of ... Discovery of Rare Gene Variants Provides Window Into Tailored Type 2 Diabetes Treatment Feb ...

Feb. 11, 2025 — Researchers have discovered a new mechanism that is used by a male sex hormone essential for ... this approach is ... How Breast Cancer Cells Survive in Bone Marrow After Remissi ...